Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome

Proteomics - Clinical Applications

Volumn 6, Issue 11-12, 2012, Pages 615-625

  Wang, Xiao Li ^a   Chai, Qiang ^a   Charlesworth, M Cristine ^a   Figueroa, Juan J ^a   Low, Phillip ^a   Shen, Win Kuang ^a   Lee, Hon Chi ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoantibodies; Cell membrane; Postural orthostatic tachycardia syndrome (POTS)

Indexed keywords

AUTOANTIBODY; CARRIER PROTEIN; CHANNEL PROTEIN; CRYSTALLIN; DESMIN; DESMOPLAKIN; FILAMIN; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN G; LAMININ; MEMBRANE PROTEIN; MIMECAN; MITOCHONDRIAL ENZYME; MYOZENIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; CARDIOMYOPATHY; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENERGY METABOLISM; FEMALE; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; INFORMED CONSENT; MALE; PILOT STUDY; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; MALE; MASS SPECTROMETRY; MIDDLE AGED; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PROTEIN INTERACTION MAPS; PROTEOME; YOUNG ADULT;

EID: 84871463034     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201200049     Document Type: Article

References (36)

1. Davidson, A., Diamond, B., Autoimmune diseases. N. Engl. J. Med. 2001, 345, 340-350.
2. Jacobson, D. L., Gange, S. J., Rose, N. R., Graham, N. M., Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 1997, 84, 223-243.
3. Rose, N. R., Mackay, I. R., Autoimmune Diseases. Academic, Oxford 2006.
4. Lee, H. C., Huang, K. T., Wang, X. L., Shen, W. K., Autoantibodies and cardiac arrhythmias. Heart Rhythm 2011, 8, 1788-1795.
5. Mathias, C. J., Low, D. A., Iodice, V., Owens, A. P. et al., Postural tachycardia syndrome-current experience and concepts. Nat. Rev. Neurol. 2012, 8, 22-34.
6. Brady, P. A., Low, P. A., Shen, W. K., Inappropriate sinus tachycardia, postural orthostatic tachycardia syndrome, and overlapping syndromes. Pacing Clin. Electrophysiol. 2005, 28, 1112-1121.
7. Huber, L. A., Pfaller, K., Vietor, I., Organelle proteomics: implications for subcellular fractionation in proteomics. Circ. Res. 2003, 92, 962-968.
8. Thieben, M. J., Sandroni, P., Sletten, D. M., Benrud-Larson, L. M. et al., Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo. Clin. Proc. 2007, 82, 308-313.
9. Wang, X. L., Ye, D., Peterson, T. E., Cao, S. et al., Caveolae targeting and regulation of large conductance Ca(2+)-activated K+ channels in vascular endothelial cells. J. Biol. Chem. 2005, 280, 11656-11664.
10. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Analyt. Chem. 2002, 74, 5383-5392.
11. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Analyt. Chem. 2003, 75, 4646-4658.
12. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S. et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome. Res. 2003, 13, 2498-2504.
13. Assenov, Y., Ramirez, F., Schelhorn, S. E., Lengauer, T. et al., Computing topological parameters of biological networks. Bioinformatics 2008, 24, 282-284.
14. Barabasi, A. L., Oltvai, Z. N., Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 2004, 5, 101-113.
15. Arrell, D. K., Zlatkovic, J., Kane, G. C., Yamada, S. et al., ATP-sensitive K+ channel knockout induces cardiac proteome remodeling predictive of heart disease susceptibility. J. Proteome Res. 2009, 8, 4823-4834.
16. Newman, M. E. J., The structure and function of complex networks. SIAM Rev. 2003, 45, 167-256.
17. Anderson, T. W., Darling, D. A., Asymptotic theory of certain "goodness of fit" criteria based on stochastic processes. Ann. Math. Stat. 1952, 23, 193-212.
18. Jahns, R., Boivin, V., Schwarzbach, V., Ertl, G. et al., Pathological autoantibodies in cardiomyopathy. Autoimmunity 2008, 41, 454-461.
19. Benrud-Larson, L. M., Dewar, M. S., Sandroni, P., Rummans, T. A. et al., Quality of life in patients with postural tachycardia syndrome. Mayo. Clin. Proc. 2002, 77, 531-537.
20. Vernino, S., Low, P. A., Fealey, R. D., Stewart, J. D. et al., Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 2000, 343, 847-855.
21. Vernino, S., Sandroni, P., Singer, W., Low, P. A., Invited article: autonomic ganglia: target and novel therapeutic tool. Neurology 2008, 70, 1926-1932.
22. Dunn, M. J., Studying heart disease using the proteomic approach. Drug Discov. Today 2000, 5, 76-84.
23. Xiang, Y., Kato, T., Use of proteomics in analysis of autoimmune diseases. Lupus 2006, 15, 431-435.
24. Petretto, E., Sarwar, R., Grieve, I., Lu, H. et al., Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat. Genet. 2008, 40, 546-552.
25. Osio, A., Tan, L., Chen, S. N., Lombardi, R. et al., Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ. Res. 2007, 100, 766-768.
26. Conway, S. J., Molkentin, J. D., Periostin as a heterofunctional regulator of cardiac development and disease. Curr. Genomics 2008, 9, 548-555.
27. Yang, Z., Bowles, N. E., Scherer, S. E., Taylor, M. D. et al., Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ. Res. 2006, 99, 646-655.
28. van Spaendonck-Zwarts, K., van Hessem, L., Jongbloed, J. D., de Walle, H. E. et al., Desmin-related myopathy: a review and meta-analysis. Clin. Genet. 2011, 80, 354-366.
29. McLendon, P. M., Robbins, J., Desmin-related cardiomyopathy: an unfolding story. Am. J. Physiol. Heart Circ. Physiol. 2011, 30, H1220-H1228.
30. Oliviero, P., Chassagne, C., Salichon, N., Corbier, A. et al., Expression of laminin alpha2 chain during normal and pathological growth of myocardium in rat and human. Cardiovasc. Res. 2000, 46, 346-355.
31. Zhou, X., Boren, J., Akyurek, L. M., Filamins in cardiovascular development. Trends Cardiovasc. Med. 2007, 17, 222-229.
32. Genth-Zotz, S., Bolger, A. P., Kalra, P. R., von Haehling, S. et al., Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. Int. J. Cardiol. 2004, 96, 397-401.
33. Linden, M., Li, Z., Paulin, D., Gotow, T. et al., Effects of desmin gene knockout on mice heart mitochondria. J. Bioenerg. Biomembr. 2001, 33, 333-341.
34. Kuhn, B., del Monte, F., Hajjar, R. J., Chang, Y. S. et al., Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 2007, 13, 962-969.
35. Chowdhury, U. R., Madden, B. J., Charlesworth, M. C., Fautsch, M. P., Proteome analysis of human aqueous humor. Invest. Ophthalmol. Vis. Sci. 2010, 51, 4921-4931.
36. Zlatkovic, J., Arrell, D. K., Kane, G. C., Miki, T. et al., Proteomics profiling of KATP channel-deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome. Proteomics 2009, 9, 1314-1325.